Literature DB >> 14585387

Change in quality of life from after left ventricular assist device implantation to after heart transplantation.

Kathleen L Grady1, Peter M Meyer, Diane Dressler, Connie White-Williams, Annemarie Kaan, Annette Mattea, Sophia Ormaza, Suzanne Chillcott, Alice Loo, Barbara Todd, Maria Rosa Costanzo, William Piccione.   

Abstract

BACKGROUND: No studies have analyzed quality of life (QOL) from before to after heart transplantation in patients with a left ventricular assist device (LVAD). Therefore, the purpose of this longitudinal, multi-site study was to compare QOL outcomes of patients listed for heart transplantation who required a left ventricular assist device (LVAD) at 3 months after implantation of an LVAD vs 3 months after heart transplantation.
METHODS: A non-random sample of 40 patients (predominantly middle-aged, married, white men), who had paired data at both 3 months after LVAD implantation and 3 months after heart transplantation, were investigated. Patients completed self-report questionnaires (with acceptable reliability and validity) at both time periods, including the Quality of Life Index, Rating Question Form, Heart Failure Symptom Checklist, Sickness Impact Profile, LVAD Stressor Scale (completed only after LVAD implant), Heart Transplant Stressor Scale (completed only after heart transplant) and Jalowiec Coping Scale. Descriptive analyses and comparative analyses using paired t-tests were performed with statistical significance set at 0.01.
RESULTS: Patients were significantly more satisfied with their lives overall and with their health and functioning at 3 months after heart transplantation as compared with 3 months after LVAD implantation. Mobility, self-care ability, physical ability and overall functional ability improved from 3 months after LVAD implant to 3 months after heart transplant. There was significantly less symptom distress after LVAD implant as compared with after heart transplant for the neurologic, dermatologic and physical sub-scales. Work/school/financial stress was significantly lower after heart transplant vs after LVAD implant. In contrast, 2 other areas of stress were significantly lower after LVAD implant vs after heart transplant: self-care stress and hospital/clinic-related stress.
CONCLUSIONS: Differences were found in QOL outcomes at 3 months after LVAD implant as compared with 3 months after heart transplant. Our findings point out specific areas of concern with respect to QOL after LVAD implant and post-transplant, some of which are amenable to health-care provider interventions.

Entities:  

Mesh:

Year:  2003        PMID: 14585387     DOI: 10.1016/s1053-2498(02)01226-3

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  12 in total

Review 1.  Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Abigale L Ottenberg; Monica R Freeman; Paul S Mueller
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 2.  Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction.

Authors:  Courtenay R Bruce; Baruch Brody; Mary A Majumder
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

3.  Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial.

Authors:  Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; Megan A Morris; Grace Venechuk; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Laura Blue; Erin L Chaussee; Russell E Glasgow; Mary Norine Walsh; Larry A Allen
Journal:  Med Decis Making       Date:  2020-04       Impact factor: 2.583

4.  Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system.

Authors:  Ryozo Omoto; Shunei Kyo; Motonobu Nishimura; Hikaru Matsuda; Goro Matsumiya; Soichiro Kitamura; Takeshi Nakatani; Shinichi Takamoto; Mdminoru Ono; Koichi Tabayashi; Ryohei Yozu
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

Review 5.  The value of psychosocial factors in patient selection and outcomes after heart transplantation.

Authors:  Erin E Coglianese; Mekhala Samsi; Max J Liebo; Alain L Heroux
Journal:  Curr Heart Fail Rep       Date:  2015-02

6.  Health-Related Quality of Life in Older Patients With Heart Failure From Before to Early After Advanced Surgical Therapies: Findings From the SUSTAIN-IT Study.

Authors:  Kathleen L Grady; Andrew Kao; John A Spertus; Eileen Hsich; Mary Amanda Dew; Duc-Thinh Pham; Justin Hartupee; Michael Petty; William Cotts; Salpy V Pamboukian; Francis D Pagani; Brent Lampert; Maryl Johnson; Margaret Murray; Koji Takeda; Melana Yuzefpolskaya; Scott Silvestry; James K Kirklin; Adin-Cristian Andrei; Christian Elenbaas; Abigail Baldridge; Clyde Yancy
Journal:  Circ Heart Fail       Date:  2022-10-10       Impact factor: 10.447

Review 7.  Functional status in left ventricular assist device-supported patients: a literature review.

Authors:  Martha Abshire; Cheryl R Dennison Himmelfarb; Stuart D Russell
Journal:  J Card Fail       Date:  2014-08-28       Impact factor: 5.712

Review 8.  LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant.

Authors:  Anne K Eshelman; Shawn Mason; Hassan Nemeh; Celeste Williams
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

9.  A review of ethical considerations for ventricular assist device placement in older adults.

Authors:  Courtenay R Bruce
Journal:  Aging Dis       Date:  2013-01-18       Impact factor: 6.745

10.  Go with the flow: progress in mechanical circulatory support.

Authors:  Martha A Abshire; Cheryl R Dennison Himmelfarb
Journal:  J Cardiovasc Nurs       Date:  2014-07       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.